The impact of coronavirus infection on all spheres of life, and
especially on the economies of many countries drawn particular
attention of states to the issue of forced licensing of the
intellectual deliverables in the health sector. Any object of
industrial property (invention, utility model, or industrial
design), whether it be the military industry, space industry,
technology sector, pharmaceuticals, agriculture, or consumer goods,
etc., is usually protected by a patent from unauthorised use. The
patent holder has the exclusive right to prohibit other persons
from commercialising the patented object without his/her permit in
the territory of the country/region, where the patent is valid. It
is the patent holder, who decides when, to whom, why, for how long,
to what extent, on what financial or other commercial terms the
right (license) to use the industrial property object would be
granted. Such licenses issued by a patentee are voluntary.